| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 0.0 | 1.2 | 0.0 |
| Other income | 0.0 | 0.1 | 0.0 |
| Total income | 0.0 | 1.2 | 0.0 |
| Profit before exceptional items & tax | -0.3 | 0.6 | -0.0 |
| Profit before tax | -0.3 | 0.6 | -0.0 |
| Net profit | -0.3 | 0.5 | -0.0 |
| Operating margin | 0.0% | 50.0% | 0.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Operating profit, quarter on quarter | -160.00% |
|---|
Source
Read the filing ↗
BSE results filing, NSE: COVIDH. Figures extracted from the filing.
iSERA Lifesciences Ltd: key numbers
- Share price
- ₹143.90
- Market cap
- ₹121.0 Cr
- Revenue (annual)
- ₹1.36 Cr
- Net profit (annual)
- ₹0.26 Cr
- P/E (TTM)
- 466.5×Sector 22.1×
- Promoter holding
- 58.63%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from iSERA Lifesciences Ltd
All →
19:30 IST
BSE
Annual Report
iSERA Lifesciences Annual Report
iSERA Lifesciences Limited has submitted its Annual Report for the financial year 2025-26. The 34th Annual General Meeting is scheduled for September 29, 2026.
19:55 IST
BSE
Financial Results
Covidh Technologies Q4 FY26 Results: Net Profit ₹0.5 Cr, Up 150.0% YoY
Covidh Technologies Ltd reported revenue from operations of ₹1.2 Cr and net profit of ₹0.5 Cr (+150.0% YoY) for Q4 FY26.
- Key figure
- Net profit ₹0.5 Cr · +150.0% YoY